Immunology and immunotherapy of human-malignant melanoma: historic review and perspectives for the future.
D000818:Animals; D000912:Antibodies, Neoplasm; D000917:Antibody Formation; D001500:BCG Vaccine / Q000627:therapeutic use; D002464:Cell Migration Inhibition; D004137:Dinitrochlorobenzene / Q000276:immunology; D006801:Humans; D007111:Immunity, Cellular; D007112:Immunity, Maternally-Acquired; D007114:Immunization; D007167:Immunotherapy / Q000379:methods; D007962:Leukocytes / Q000276:immunology; D008213:Lymphocyte Activation; D008545:Melanoma / Q000188:drug therapy / Q000276:immunology* / Q000628:therapy; D009368:Neoplasm Transplantation; D012313:RNA / Q000276:immunology; D012878:Skin Neoplasms / Q000188:drug therapy / Q000276:immunology* / Q000628:therapy; D014165:Transfer Factor; D014184:Transplantation, Homologous
D000912:Antibodies, Neoplasm; D001500:BCG Vaccine; D004137:Dinitrochlorobenzene; D014165:Transfer Factor; D012313:RNA